Butt Tausif 4
4 · ChemoCentryx, Inc. · Filed May 10, 2021
Insider Transaction Report
Form 4
Butt Tausif
EVP, Chief Operating Officer
Transactions
- Purchase
Common Stock
2021-05-07$11.06/sh+10,870$120,241→ 10,870 total
Footnotes (1)
- [F1]Reflects the weighted average sale price of the shares purchased. The shares were purchased in multiple trades at prices ranging from $11.02 to $11.12 per share. The Reporting Person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.